PrecisionPhage

PrecisionPhage

PrecisionPhage is a Finland-based biotechnology company focused on bacteriophages and their use in treating antibiotic resistant bacterial infections. The company combines computational and laboratory capabilities to support phage discovery, characterization, and genomic quality assessment. Its software includes Phagenomics Core, a no-code platform for bacteriophage genome assembly, annotation, and genomic comparison, and Phagenomics BatchQC, a GMP-compatible system that supports verification of genome integrity, contamination detection, and batch documentation for production and reporting. BatchQC is intended for GMP-grade genomic quality control in biologics manufacturing and is designed with the highest standards of data traceability and compliance requirements in mind. PrecisionPhage also provides services such as phage isolation and characterization, DNA preparation and sequencing, bioinformatic analysis and consultation, and laboratory R&D. In addition, the company maintains a curated phage library with licensing options for research and commercial use. From its sites of operation in Finland, PrecisionPhage works with academic and industrial partners internationally to support phage-based applications. The company does not provide medical treatments or clinical phage therapy directly.

VISIT WEBSITE

Subscribe To Our Newsletter

Join our mailing list to get updated with our latest news and events!

Contact Information
  • Lee Kong Chian School of
    Medicine,
    Clinical Sciences Building
    11 Mandalay Road #16-01
    Singapore 308232

  • +65 6513 6058
Members Login

co11ab Novena (co11ab) is a Bio MedTech incubator – forged through a tripartite alliance between Nanyang Technological University, Singapore (NTU Singapore), Agency for Science, Technology, and Research (A*STAR), and National Healthcare Group (NHG) – which aims to nurture and support the translational development of biomedical technologies. Our key focus areas are biotech, medtech and digital health.